Original Sources · Chapter 18

A Second Opinion

Film time 00:50:39–00:57:58 · 7:19 long. Watch the chapter, then open each original source it uses, right here on the page.

Chapter 18 · 0:00 / 7:19 · film time 00:50:39

Sources in this chapter (22)

Click a timecode to jump the chapter player to the moment the source appears. Sources marked “Play the original here” load the original footage from its host only when you press play.

  1. 100:51:02

    A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics. The New England Journal of Medicine,

    doi.org · 2019 · Study/journal

    PALM Ebola trial (NEJM Dec 2019)

  2. 200:52:03

    Data from remdesivir coronavirus drug trial shows ‘quite good news’: Dr. Anthony Fauci

    YouTube · 2020 · Video

    Fauci Oval Office: remdesivir 'quite good news'

  3. 300:52:54

    Dr. Anthony Fauci says Gilead’s remdesivir will set a new ‘standard of care’ for coronavirus treatment

    CNBC · 2020 · News article

    Fauci: remdesivir will be 'standard of care'

  4. 400:52:54

    Ten experts on a NIH COVID-19 panel have ties to companies involved in coronavirus treatment

    Just The News · 2020 · News article

    NIH panel members with industry ties

  5. 500:53:12

    Dr. Jason Fung: Financial Conflicts of Interests and the End of Evidence-Based Medicine

    YouTube · 2019 · Video

    Dr. Jason Fung's 2019 talk on conflicts of interest

  6. 600:53:45

    April 27, 2020, Gilead drops on report remdesivir flopped in trial

    CNBC · 2020 · Video

    Report remdesivir trial in China failed

    The original Broken Truth post on X was deleted; this archived copy of the CNBC segment plays from our server. The on-screen ticker in this copy may read April 23, 2020.

    Source: Original post on X (removed by host)

  7. 700:54:36

    WATCH: Senators hear update on early outpatient treatment for COVID-19

    YouTube · 2020 · Video

    Senate hearing on early outpatient treatment (Jha)

  8. 800:54:58

    BIOMEDICAL RESEARCH Information on Federal Contributions to Remdesivir Report to Congressional Addressees

    gao.gov · 2021 · Government/official doc

    Federal (NIH) contributions to remdesivir

  9. 900:55:09

    FDA allows emergency use of remdesivir to treat coronavirus patients after promising study

    Fox News · 2020 · News article

    FDA emergency use of remdesivir

  10. 1000:55:25

    Dr. Harvey Risch Live on New Day

    CNN · 2020 · Video

    Risch on CNN New Day

    The original Broken Truth post on X was deleted; this archived copy of the CNN New Day segment (Aug. 3, 2020) plays from our server.

    Source: Original post on X (removed by host)

  11. 1100:55:50

    FDA Advisory committee doctors discuss opioid labeling

    YouTube · 2019 · Video

    FDA opioid advisory committee

  12. 1200:55:52

    RT America video (2019)

    RT America · 2019 · Video

    The original Facebook video no longer plays (Facebook: “Video Unavailable”).

  13. 1300:56:03

    FDA Stands By Approval of OxyContin - Judge for Yourselves

    Judge for Yourselves · 2021 · News article

    FDA OxyContin approval

  14. 1400:56:44

    Post on X by @SenRandPaul

    Rand Paul / Anthony Fauci Testimony · 2023 · Social post

    Fauci vs. Rand Paul ('Senator, it is you')

  15. 1500:56:53

    NIH Implements Royalty Disclosure Policy Five Years After Promised - California Healthline

    California Healthline · 2023 · News article

    Royalty disclosures (Bayh-Dole)

  16. 1600:56:53

    Bayh–Dole Act

    Wikipedia · 2023 · Other

    Bayh-Dole Act

  17. 1700:57:00

    Hidden conflicts? Pharma payments to FDA advisers after drug approvals spark ethical concerns

    Science.org · 2021 · News article

    Pharma payments to FDA advisers

  18. 1800:57:00

    After-the-fact Pharma Payments to FDA Advisers Spark Ethical Concerns

    Mad In America · 2018 · News article

    Pharma payments to FDA advisers

  19. 1900:57:35

    Pfizer to make Gilead’s COVID-19 treatment remdesivir

    Reuters · 2020 · News article

    Pfizer to make remdesivir

  20. 2000:57:40

    What The Pfizer-Mylan Deal Means For Pharma. Forbes

    29 Jul · 2019 · News article

    Pfizer-Mylan deal

  21. 2100:57:40

    Mylan launches generic version of Remdesivir in India for COVID-19 patients

    The Hindu · 2020 · News article

    Mylan makes generic remdesivir

  22. 2200:57:40

    End of an era: Mylan workers leave Morgantown plant with fond memories - WV MetroNews

    WV MetroNews · 2021 · News article

    Mylan West Virginia plant closed

Chapter transcript
  1. 00:50:43 Our next presenter is
  2. 00:50:45 Dr Paul Marik.
  3. 00:50:47 He has written over 500 peer-reviewed journal articles,
  4. 00:50:50 80 book chapters,
  5. 00:50:51 and authored four critical care books and has been cited over 48,000 times in peer-reviewed publications.
  6. 00:50:58 Merrick is certainly one of those doctors who've been persecuted for treating patients.
  7. 00:51:02 The Palm Study Group investigated four drugs for the use of Ebola.
  8. 00:51:10 The results were published December the 12th,
  9. 00:51:14 2019 in the New England Journal of Medicine.
  10. 00:51:17 And that date is particularly important because that signaled the beginning of COVID.
  11. 00:51:24 Remdesivir increased the risks of death and renal failure.
  12. 00:51:31 It was such a toxic drug,
  13. 00:51:33 the Data Safety Monitoring Board terminated the use of Remdesivir.
  14. 00:51:39 The NIH and the Act One study enrolled patients in a study looking at Remdesivir for the treatment of COVID-19.
  15. 00:51:51 The last patient was enrolled April 19,
  16. 00:51:56 2020.
  17. 00:51:57 Ten days later,
  18. 00:51:59 ten days later,
  19. 00:52:00 before the study had actually terminated,
  20. 00:52:03 Dr Fauci sat in the Oval Office of the White House and he said the trial was good news.
  21. 00:52:11 What Dr Fauci did not tell you was that the primary endpoint of the study was changed halfway during the study.
  22. 00:52:22 We all know that is scientific misconduct.
  23. 00:52:26 Because the study was not going to be positive,
  24. 00:52:30 they changed the primary endpoint.
  25. 00:52:32 They invented a bogus endpoint called time to recovery,
  26. 00:52:38 which they showed in this study was statistically significant.
  27. 00:52:42 And based on this bogus endpoint,
  28. 00:52:46 Remdesivir was approved by the FDA on October the 20th, 2020
  29. 00:52:54 The data shows that Remdesivir has a clear-cut significant positive effect in diminishing the time to recovery.
  30. 00:53:06 It was 11 days compared to 15 days.
  31. 00:53:09 This will be the standard of care.
  32. 00:53:11 The standard of practice is set by a number of physicians who have a large amount of conflicts of interest.
  33. 00:53:19 The people who lead these guideline committee,
  34. 00:53:21 they're on the take.
  35. 00:53:23 But the problem is that people die.
  36. 00:53:25 So we would have normally waited several days until the data gets further,
  37. 00:53:30 dot the I and cross the T.
  38. 00:53:32 But the data are not going to change.
  39. 00:53:34 Some of the numbers may change a little,
  40. 00:53:37 but the conclusion will not change.
  41. 00:53:39 If Big Pharma does a study that shows that its drug is no good,
  42. 00:53:43 it has the option of not publishing it.
  43. 00:53:45 But this was a study conducted in China.
  44. 00:53:47 It was terminated early and it failed to show any benefit for Remdesivir versus the standard of care.
  45. 00:53:55 Almost every single patient in this country is treated with the combination of Remdesivir and low-dose dexamethasone.
  46. 00:54:07 But just to make the situation even more preposterous,
  47. 00:54:11 the federal government will give hospitals a 20% bonus on the entire hospital bill if they prescribe Remdesivir to Medicare patients.
  48. 00:54:26 The federal government is incentivizing hospitals to prescribe a medication which is toxic.
  49. 00:54:36 The hydroxychloroquine cocktail,
  50. 00:54:38 it's about $20,
  51. 00:54:40 right?
  52. 00:54:40 Certainly no more than 50.
  53. 00:54:43 Remdesivir,
  54. 00:54:44 and we'll talk about that a little bit later in terms of the side effects of that and the studies,
  55. 00:54:48 the science behind that,
  56. 00:54:50 costs over $3,000.
  57. 00:54:51 Could that maybe be one of the reasons why all the effort is
  58. 00:54:55 put on these more exotic therapeutics that cost thousands of
  59. 00:54:58 dollars versus something that's off the shelf that costs $20?
  60. 00:55:02 We want to thank all the collaborators that have brought Remdesivir to this point,
  61. 00:55:06 and that certainly includes NIH and Dr. Fauci
  62. 00:55:09 We authorized Gilead's application for emergency use authorization.
  63. 00:55:14 This was lightning speed in terms of getting something approved,
  64. 00:55:17 and from clinical trial to getting it authorized from the FDA,
  65. 00:55:21 it's been quite the speedy but also effective process.
  66. 00:55:24 The FDA has a huge history of drugs going into widespread
  67. 00:55:27 use in the medical community for decades that have not been
  68. 00:55:31 established on the basis of randomized controlled trials.
  69. 00:55:34 the fact that it's an existing drug,
  70. 00:55:36 that helps,
  71. 00:55:37 but you still got to go through trials.
  72. 00:55:39 You still got to go through trials.
  73. 00:55:42 The FDA makes a decision which is sometimes totally independent of any finding by the advisory committee.
  74. 00:55:50 Dr Rayford Brown chairs the FDA Opioid Advisory Committee.
  75. 00:55:54 According to Dr. Brown
  76. 00:55:56 the FDA is putting the interests of Big Pharma ahead of public health.
  77. 00:56:00 They're proving the painkiller OxyContin.
  78. 00:56:03 The FDA didn't even require Purdue Pharma to undergo clinical trials.
  79. 00:56:14 Opioid company, Purdue,
  80. 00:56:15 gave a lot of money to the doctors to say that,
  81. 00:56:18 Hey, if you are in pain,
  82. 00:56:20 you can't get addicted." It's like,
  83. 00:56:23 that actually wasn't true at all,
  84. 00:56:24 but that's what I was taught in medical school.
  85. 00:56:26 If you're in pain,
  86. 00:56:27 you can't be addicted.
  87. 00:56:28 I'm quoting,
  88. 00:56:29 "The FDA has a lack of transparency and uses the advisory committees as cover." The agencies turned a blind eye toward simple,
  89. 00:56:38 cheap,
  90. 00:56:38 possibly effective treatments that,
  91. 00:56:41 created no harm.
  92. 00:56:44 According to the regulations,
  93. 00:56:46 people who receive royalties are not required to divulge them,
  94. 00:56:50 even on their financial statement,
  95. 00:56:53 according to the Bayh-Dole Act.
  96. 00:56:55 The hydroxychloroquine FDA Advisory Committee lists significant conflicts of interest.
  97. 00:57:00 Some conflicts have not been properly disclosed.
  98. 00:57:03 Half of the chemotherapy drugs used in cancer were used without randomized controlled trials.
  99. 00:57:08 The antibiotics,
  100. 00:57:09 amoxicillin,
  101. 00:57:09 for example,
  102. 00:57:10 that parents use with their children all the time,
  103. 00:57:12 day in,
  104. 00:57:13 day out,
  105. 00:57:13 was never established with a randomized controlled trial before it was used.
  106. 00:57:17 China stopped the studies because they couldn't fully enroll them,
  107. 00:57:19 because they stopped accruing cases in China,
  108. 00:57:22 because their epidemic had subsided,
  109. 00:57:23 because their epidemic had subsided.
  110. 00:57:25 This accidental admission that China has beaten the virus was brought to you by former FDA Commissioner Scott Gottlieb.
  111. 00:57:31 Scott's a board member of the company Pfizer.
  112. 00:57:33 Four months after this interview,
  113. 00:57:35 Pfizer announced it was manufacturing Gilead's very expensive remdesivir.
  114. 00:57:39 In 2019,
  115. 00:57:40 Pfizer purchased a company called Mylon.
  116. 00:57:42 Mylon used to make hydroxychloroquine in West Virginia,
  117. 00:57:45 but after Pfizer got hold of it,
  118. 00:57:47 they shut it down.
  119. 00:57:48 In July of 2020,
  120. 00:57:49 Mylon announced it would make the generic version of remdesivir for Gilead.
  121. 00:57:52 Non of these conflicts of interest were disclosed by CNBC.
  122. 00:57:55 I don't know why people weren't more positive all along about remdesivir.

Full citations for the whole film stay in the Bibliography. Third-party footage belongs to its owners and is shown from its original host for reference. Spotted a missing or dead source? Press@EpidemicOfFraud.com

← All chapters